Bank of America Global Research upped its rating on Regeneron Pharmaceuticals and its price target to $860 because it has a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback